Cash Piles, Hostile Bids Set Stage for a Wild Japan M&A Year
...ng to raise at least $5 billion for its second Asian private equity fund. In August, Blackstone agreed to buy Takeda Pharmaceutical Co.’s over-the-counter drug business for 242 billion yen, its largest acquisition in Jap...
Read Full Article
